Cytokines at the research-clinical interface: potential applications

Area of Science:

• Hematology
• Molecular Biology
• Immunology

Background:

• Colony-stimulating factors were discovered using haemopoietic colony assays in the 1960s.
• Molecular biology advancements in the 1980s enabled industrial-scale production of cloned growth factors.
• Early clinical applications involved single-agent cytokines like erythropoietin and interferons.

Purpose of the Study:

• To review the evolution of growth factor characterization and clinical applications.
• To highlight recent advancements in understanding and utilizing cytokines.
• To focus on newly characterized growth factors and their potential.

Main Methods:

• Review of historical developments in growth factor research.
• Analysis of clinical trial data on cytokine combinations.
• Focus on recently characterized growth factors: c-kit ligand, flt3 ligand, c-mpl ligand/thrombopoietin, and specific interleukins.

Main Results:

• Growth factors have progressed from basic discovery to complex clinical applications.
• Cytokines are increasingly investigated for combined or sequential administration.
• Current applications include progenitor cell mobilization and amelioration of cytopenias.

Conclusions:

• Future cytokine applications may involve ex vivo stem cell expansion, improved gene therapy, gastrointestinal protection, and immunomodulation.
• Optimizing cytokine combinations and timing is crucial for future therapies.
• Continued research into novel growth factors promises expanded therapeutic potential.